Christopher R. Fenimore - 12 Dec 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
SVP Controller
Signature
/s/**Christopher R. Fenimore
Issuer symbol
REGN
Transactions as of
12 Dec 2023
Net transactions value
-$2,186,324
Form type
4
Filing time
14 Dec 2023, 16:08:17 UTC
Previous filing
12 Dec 2023
Next filing
26 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Tax liability $2,186,324 -2,552 -12% $856.71 18,750 12 Dec 2023 Direct
holding REGN Common Stock 1,473 12 Dec 2023 2021 GRAT
holding REGN Common Stock 4,269 12 Dec 2023 2022 GRAT
holding REGN Common Stock 1,499 12 Dec 2023 By 401(k) Plan
holding REGN Common Stock 1,897 12 Dec 2023 By Trust F1
holding REGN Common Stock 461 12 Dec 2023 by Trust for Daugh
holding REGN Common Stock 460 12 Dec 2023 by Trust for Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.